Expert Call:
(86) 23-86916205
Accelerating Precision Diagnostics Through Advanced Chemiluminescence Technology
Chemiluminescence Immunoassay (CLIA)
Chemiluminescence Immunoassay (CLIA) has become one of the most widely adopted technologies in modern in vitro diagnostics due to its exceptional sensitivity, broad analytical range, and compatibility with high-throughput automated laboratory systems. From infectious disease screening and tumor marker analysis to endocrine and cardiac testing, CLIA platforms play a critical role in improving diagnostic efficiency and clinical decision-making.
IVDCDMO provides comprehensive CLIA development and manufacturing solutions covering assay development, reagent optimization, instrument integration, analytical validation, pilot production, regulatory documentation, and scalable manufacturing support. Our multidisciplinary teams support both emerging IVD innovators and established diagnostic brands throughout the entire commercialization lifecycle.
IVDCDMO provides comprehensive CLIA development and manufacturing solutions covering assay development, reagent optimization, instrument integration, analytical validation, pilot production, regulatory documentation, and scalable manufacturing support. Our multidisciplinary teams support both emerging IVD innovators and established diagnostic brands throughout the entire commercialization lifecycle.
Understanding CLIA Principles and Workflow
Chemiluminescence Immunoassay is an advanced immunodiagnostic technology that combines highly specific antigen-antibody reactions with chemiluminescent signal detection. The method converts biochemical reactions into measurable light signals, allowing accurate quantification of target biomarkers even at extremely low concentrations.
Compared with conventional ELISA technologies, CLIA systems offer:
Higher analytical sensitivity
Wider dynamic detection range
Faster turnaround times
Lower sample volume requirements
Improved automation compatibility
Enhanced reproducibility in large-scale testing environments
Modern CLIA platforms are extensively used in:
Infectious disease diagnostics
Tumor marker detection
Thyroid and endocrine testing
Cardiac biomarker analysis
Autoimmune disease diagnostics
Fertility and reproductive health testing
Therapeutic drug monitoring (TDM)
The rapid expansion of decentralized healthcare, preventive screening programs, and precision medicine initiatives continues to drive global demand for high-performance CLIA solutions.
Compared with conventional ELISA technologies, CLIA systems offer:
Higher analytical sensitivity
Wider dynamic detection range
Faster turnaround times
Lower sample volume requirements
Improved automation compatibility
Enhanced reproducibility in large-scale testing environments
Modern CLIA platforms are extensively used in:
Infectious disease diagnostics
Tumor marker detection
Thyroid and endocrine testing
Cardiac biomarker analysis
Autoimmune disease diagnostics
Fertility and reproductive health testing
Therapeutic drug monitoring (TDM)
The rapid expansion of decentralized healthcare, preventive screening programs, and precision medicine initiatives continues to drive global demand for high-performance CLIA solutions.
Our CLIA Development Approach
End-to-End CLIA CDMO Capabilities
IVDCDMO supports full-cycle CLIA assay and platform development through integrated scientific, engineering, manufacturing, and regulatory expertise.
Our service model includes:
IVDCDMO supports full-cycle CLIA assay and platform development through integrated scientific, engineering, manufacturing, and regulatory expertise.
Our service model includes:
Antibody pair screening and validation
Antigen design and optimization
Chemiluminescent substrate selection
Signal amplification optimization
Sensitivity and specificity enhancement
Cross-reactivity assessment
Antigen design and optimization
Chemiluminescent substrate selection
Signal amplification optimization
Sensitivity and specificity enhancement
Cross-reactivity assessment
Buffer formulation optimization
Stability enhancement studies
Lyophilization development
Magnetic bead coupling optimization
Conjugation chemistry refinement
Shelf-life validation
Stability enhancement studies
Lyophilization development
Magnetic bead coupling optimization
Conjugation chemistry refinement
Shelf-life validation
Open platform adaptation
Automated analyzer compatibility
Throughput optimization
Sample handling workflow integration
Calibration system development
Software and algorithm support
Automated analyzer compatibility
Throughput optimization
Sample handling workflow integration
Calibration system development
Software and algorithm support
Precision and repeatability studies
Linearity verification
Limit of detection (LOD) analysis
Interference testing
Method comparison studies
Clinical performance evaluation
Linearity verification
Limit of detection (LOD) analysis
Interference testing
Method comparison studies
Clinical performance evaluation
GMP-compliant production systems
Batch consistency management
Automated filling and packaging
Cold-chain logistics support
OEM/ODM manufacturing
Global supply chain coordination
Batch consistency management
Automated filling and packaging
Cold-chain logistics support
OEM/ODM manufacturing
Global supply chain coordination
Build Your Next CLIA Diagnostic Platform with Confidence
Whether you are developing a novel immunodiagnostic assay, expanding an existing testing menu, or scaling global manufacturing operations, IVDCDMO provides the technical expertise and production capabilities required for successful commercialization.
Tips, News & Updates
CDMO Custom Development of Test Kits: From Assay Concept to Scalable IVD Manufacturing
CDMO custom development of test kits provides diagnostic companies with a structured route from an initial assay concept to a reproducible, manufacturable and commercially viable in vitro diagnostic product. Instead of outsourcin...
Quick Contact
If you have any questions or need help, feel free to contact with our team.
2F, Science & Technology Incubation Building, Chongqing Banan International Biocity,China